Market Overview:
The North
America Drug Screening Market has been growing at an incremental pace
and is expected to capture a CAGR of 6% over the forecast period of 2017-2023,
proclaims Market Research Future (MRFR) in an exhaustive research report.The
North America drug screening market derives much of its growth from the growing
illicit use of drugs in the region and growing awareness regarding the same.
Rising prevalence of alcohol use disorder and illegal
use of drugs provide impetus to the North America drug screening market.Drug
screening is a standard process in North
America for acquiring jobs in airlines, railways, government jobs and in places
where public safety is involved which boots the growth of the market. Businesses
rely on drug testing of employees as illicit drug use,or abuse can be detrimental in the workplace. With various businesses mandating drug screening in North
America in an aim to increase productivity and reduce medical costs, the North
America drug screening market has been able to flourish in the region. More
schools in the US than ever before have mandated drug screening of students as
drug abuse by students has become a common phenomenon.
Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/1507
Drug
screening of student athletes too is
permissible in North America. Furthermore,
the U.S. Anti-Doping Agency (USADA) has strict protocols pertaining to drug screening of athletes
participating in national and international sports which bolsters the growth of
the North America Drug Screening market.
Competitive Landscape:
Siemens
Healthnieers, Quest Diagnostics, Thermo Fisher Scientific, Inc., Laboratory
Corporation of America Holdings, Roche Diagnostics, Express Diagnostics Int'l
Inc., Shimadzu Corporation, Alere Toxicology, and MPD.
Segmentation:
·
The North America drug screening market has been segmented based on test sample and
conditions.
·
By test sample, the market has been
segmented into Urine, Hair, Blood, and Saliva.
·
By condition, the market
has been segmented into Unconsciousness,
Chest Pain, Panic Attack, Drug Allergies, and Others.
Regional Analysis:
The North America drug screening market
covers the US and Canada. These regions have substantially high population
bases who are involved in drug abuse
which drives the market. North America has established stringent anti-doping
regulations which support the drug screening market. Moreover, development of
drug and alcohol screening devices such as organ-on-a-chip technology and rising
disposable income in the region spurs the growth of the market.
Industry Updates:
In August 2018, Bluechiip, a technology company,
extended its existing agreement with Labcon North America, to supply Labcon
with chips and associated hardware necessary for drug screening. The deal is
worth USD 11.6 Million and will extend upto
three years.
Related
Infographics Links
Chemotherapy Market Research Report -
Global Forecast till 2024
https://www.marketresearchfuture.com/infographics/chemotherapy-market
Cell
Therapy Market Research Report- Global Forecast till 2023
https://www.marketresearchfuture.com/infographics/cell-therapy-market
No comments:
Post a Comment